Investing Profile

Frank Kalkbrenner

InvestorVC
VicePresident R&D Licensing and Information Management at Hotmail
boehringer-ingelheim-venture....Germany
Photo of Frank Kalkbrenner, Hotmail
Your Intro Paths to Frank Kalkbrenner

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Frank is a member of
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Bayer Network
18 CONNECTIONS
Boehringer Ingelheim Network
17 CONNECTIONS

Find Frank Kalkbrenner on

cb
Current Investing Position
Hotmail
Investment Range
$3.3M - $17.0M
Sweet Spot
$8.5M
Investments On Record
9

Frank Kalkbrenner is on these Sector & Stage Rankings

Frank Kalkbrenner's Investments On Record (4)

CompanyStageDateRound SizeTotal Raised
Rinri Therapeutics
Series UnknownApr 2021$12M
$14M
Co-investors: Claire Brown (Oxford Science Enterprises)
T3 Pharmaceuticals
Series CJul 2020$27M
Series BSep 2019$12M
$39M
Amal Therapeutics
Series BNov 2018$33M
Series BSep 2017$10M
Series AMar 2016$3M
$46M
Co-investors: Frank Hensel (HTGF | High-Tech Gründerfonds)
Hookipa Pharma
Series CDec 2017$60M
Series BDec 2016$11M
Series BNov 2013$27M
$110M
Co-investors: Graziano Seghezzi (Sofinnova Partners)

Frank Kalkbrenner's Experience

Post-doctoral fellow HotmailPresent
Research Group Leader, Institute of Pharmacology Freie Universität BerlinPresent
Senior Scientist, Dermatology Research BayerPresent
Senior Scientist, Pulmonary Research Boehringer IngelheimPresent
Director, Pulmonary Research Boehringer IngelheimPresent
VicePresident R&D Licensing and Information Management HotmailPresent
Director, Investment Manager HotmailPresent

Frank Kalkbrenner's Education

Freie Universität Berlin Dr. med. Medizin